|
TVIS44027439
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr17 |
35662175 |
35662175 |
q12 |
AP2B1 |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44027440
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr17 |
3585395 |
3585395 |
p13.2 |
TRPV1, ENSG00000262304 |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44027441
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr17 |
36465714 |
36465714 |
q12 |
- |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44027442
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr17 |
36752559 |
36752559 |
q12 |
ENSG00000275613 |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44027443
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr17 |
37215033 |
37215033 |
q12 |
ACACA |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44027444
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr17 |
38278867 |
38278867 |
q12 |
- |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44027445
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr17 |
39812785 |
39812785 |
q21.1 |
IKZF3 |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44027446
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr17 |
4000868 |
4000868 |
p13.2 |
- |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44027447
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr17 |
43135817 |
43135817 |
q21.31 |
NBR2, BRCA1 |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |
|
TVIS44027448
|
Human T-lymphotropic Virus |
- |
Not given |
- |
- |
hg19 |
chr17 |
43728379 |
43728379 |
q21.31 |
- |
Nontumor |
Not given |
High throughput sequenicng |
29186194 |
2017 |
VISDB1.0 |